Erratum to: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas (Nature, (2017), 10.1038/nature24040)

Hezhe Lu, Shujing Liu, Gao Zhang, Bin Wu, Yueyao Zhu, Dennie T. Frederick, Yi Hu, Wenqun Zhong, Sergio Randell, Norah Sadek, Wei Zhang, Gang Chen, Chaoran Cheng, Jingwen Zeng, Lawrence W. Wu, Jie Zhang, Xiaoming Liu, Wei Xu, Clemens Krepler, Katrin SproesserMin Xiao, Benchun Miao, Jianglan Liu, Claire D. Song, Jephrey Y. Liu, Giorgos C. Karakousis, Lynn M. Schuchter, Yiling Lu, Gordon Mills, Yusheng Cong, Jonathan Chernoff, Jun Guo, Genevieve M. Boland, Ryan J. Sullivan, Zhi Wei, Jeffrey Field, Ravi K. Amaravadi, Keith T. Flaherty, Meenhard Herlyn, Xiaowei Xu, Wei Guo

    Research output: Contribution to journalComment/debate

    Abstract

    In this Letter, two relevant references were omitted; see the accompanying Amendment for details. The original Letter has not been corrected.

    Original languageEnglish (US)
    Pages (from-to)E4
    JournalNature
    Volume565
    Issue number7738
    DOIs
    StatePublished - Jan 10 2019

    ASJC Scopus subject areas

    • General

    Fingerprint Dive into the research topics of 'Erratum to: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas (Nature, (2017), 10.1038/nature24040)'. Together they form a unique fingerprint.

  • Cite this

    Lu, H., Liu, S., Zhang, G., Wu, B., Zhu, Y., Frederick, D. T., Hu, Y., Zhong, W., Randell, S., Sadek, N., Zhang, W., Chen, G., Cheng, C., Zeng, J., Wu, L. W., Zhang, J., Liu, X., Xu, W., Krepler, C., ... Guo, W. (2019). Erratum to: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas (Nature, (2017), 10.1038/nature24040). Nature, 565(7738), E4. https://doi.org/10.1038/s41586-018-0814-7